The NIH’s Small Business Innovation research (SBIR) program is a set-aside program for small business concerns to engage in research and development that has the potential for commercialization. Nano3D was awarded a Phase I SBIR grant for work associated with its recent proposal, titled “Novel 3D high-content/throughput assay with mobile device-based data acquisition.”
Alongside RBCC, n3D is working to market and develop the BiO Assay: the world’s first commercially available 3D bioprinting system designed for high throughput and high-content drug screening. The automated toxicity assay uses biocompatible magnetic nanoparticles to print cells into 3D structures much faster and more affordably than competing bioprinting tech currently on the market.
Nano3D’s winning proposal details a 3D model that is rapid, quantitative, and representative for high-throughput toxicity testing to meet these needs by magnetically printing 3D cultures.
“We’re immensely gratified that the NIH recognizes the unprecedented research potential of the Bio Assay,” said RBCC CEO
RBCC formed a biotech subsidiary, Rainbow Biosciences, to market and develop new medical and research technology innovations such as the BiO Assay to compete alongside companies such as
About Rainbow Biosciences
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
President and CEO
Most Popular Stories
- Hispanic Entrepreneurs Short-changed in Texas
- Washington's 'The Equalizer' Debuts With $35 Million
- Is North Korea's Kim Jong Ill?
- International Coffee Day Means Free Coffee at Dunkin' Donuts, Krispy Kreme, McDonalds
- Pending U.S. Home Sales Slid in August
- Jerry Brown Signs 'Yes Means Yes' Law
- Drunk Driver Rear Ends Jennifer Lopez, Leah Remini's Car
- George Clooney Says 'I Do' For a Second Time
- GoPro Launching Three New Cameras
- Macy's Boosts Holiday Hiring 3.6 Percent